Sequence analyses of HIV-1 Gag and Nef from treatment and placebo arms.Maximum-likelihood phylogenetic trees of bulk Gag sequences (Panel A) and clonal Nef sequences (panel B) from participants who received 1% tenofovir gel (red) or placebo (black) demonstrated no major clustering between arms of the trial. HIV-1 subtype B reference sequence HXB2 is shown in green."
